The sales figures are in from Colorado for January 2016, and while they are down from the previous month, the figures are still substantial. Last year the State of Colorado sold just shy of one billion dollars worth of cannabis. This year virtually all projections have Colorado eclipsing the one billion dollar mark, and the sales figures from January would put Colorado ahead of that pace. Per The Cannabist:

It’s been a winning day for some pharmaceutical companies making drugs based on marijuana.

Especially for those treating epilepsy.

After GW Pharmaceuticals announced that it had successfully treated a form of epilepsy using its cannabis-based drug Monday, Pennsylvania-based drugmaker Zynerba Pharmaceuticals stock also rose in concert by 150% during trading Monday.

Zynerba continued its rise 7% in after hours trading.

For the week ended Friday, March 11, the spot price index for a pound of cannabis was essentially unchanged from $1,920 in the prior week to $1,918. The simple average price for a gram slipped a penny from $4.57 to $4.56.

The futures price for the near month (April) rose 1% from $2,010 to $2,030. For the month of May, the forward price remained flat at $2,110 a pound. The six-month forward price for September also remained unchanged at $2,200.

About two-thirds of the past week’s transactions occurred in a range of $1,564 to $2,577 per pound, according to the analysts at Cannabis Benchmarks. The analysts also commented on the forward price curve:

The Lib Dems have adopted a plan legalise cannabis shops as their party policy. 

Their party wants to see:

• Licensed shops sell cannabis to over 18s
• The strength of cannabis regulated
• Smokers allowed to grow plants at home
• Plain packaging with health information

But how many people in Wales use cannabis or other drugs?

How many of us smoke cannabis?

6.1% of adults (under 59) in Wales say they smoked cannabis at least once last year.

An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, more than doubling the value of its maker GW Pharmaceuticals.

The study of GW's Epidiolex in Dravet syndrome is the first of four final-stage Phase III epilepsy trials, with results expected this year, that the drugmaker hopes will confirm the therapeutic benefits of cannabinoids, the active ingredients found in marijuana.

TORONTO - You won't find brightly coloured bongs or bubble gum-flavoured rolling papers displayed against the backdrop of exposed brick and modern, industrial-style furnishings at Tokyo Smoke.

Instead, the shop - located in a former shipping dock nestled between two warehouses in Toronto's west end - carries high-end pot paraphernalia befitting the pages of a design magazine while also serving up cups of artisanal coffee.

Pipes handcrafted by California-based ceramicist Ben Medansky sit alongside a pricey portable vaporizer, a reimagined version of the French press coffeemaker launched via a Kickstarter campaign and a selection of what shop owner Alan Gertner calls "museum quality collectibles" - items such as vintage Barbies and a vintage Hermes bag.

As a lawyer for the Cannabis industry, Steve Schain says he helps entrepreneurs, “dodge landmines” and hold onto their revenue. He works on marijuana finance and business issues including application submission, regulation interpretation, and lawsuits. Here he lays out five important things for any budding entrepreneur to remember when they embark on a cannabusiness venture.

If You “Touch The Product” Things Are Much Stricter.  

Colorado Springs isn't alone in banning cannabis clubs. Washington state did so last summer, and Portland, Ore., followed suit this month.

Englewood, Colo., was set to ban them but decided to extend its moratorium to June 15 while it explores how to regulate them instead.

But while the Colorado Springs City Council on Tuesday ordered cannabis clubs to phase out their businesses over the next eight years, Denver residents will vote Nov. 8 on an initiative to license and regulate the clubs.

One of the oldest and largest immigration law firms in the Rocky Mountain West says it’s seeing a growing number of immigrants coming to Colorado to take part in the state’s so-called “green rush” of legal marijuana businesses, only to have their hopes of financial success quickly dashed and their futures in the United States put at risk.

Attorneys at Denver-based Lau and Choi, P.C. say many immigrants are flocking to Colorado because of rumors that they can legally grow 99 marijuana plants there.

“We’re concerned that there’s a lot of rumors and misinformation among immigrants, particularly in the Chinese community, regarding the legality of marijuana in Colorado,” says Charles “Mac” McIntyre IV, a Mandarin-fluent attorney at Lau & Choi.

Some people within marijuana’s business culture still wear the “stoner” label with pride; showing solidarity with the men and women who brought cannabis into national awareness more than a half-century ago.

But times have surely changed and the legal cannabis industry has evolved into something that most marijuana enthusiasts in the 60s, 70s and 80s would have considered a pipe dream: a legitimate, multi-billion-dollar industry that Washington, D.C., Wall Street and other parts of America’s political and economic sector now scrutinize closely.